Strategic Clinical Research Group

Willow Park, Texas 76087

2 studies enrolling now · 11 studies all time

What they study most

Diabetes Mellitus, Diabetic Macular Edema, Diabetic Retinopathy, Geographic Atrophy, Macular Degeneration, Neovascular Age-related Macular Degeneration, Stargardt's Macular Dystrophy

Studies at this site

• A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated — Recruiting now
• A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — Recruiting now
• A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1) — Completed
• Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) — Completed
• A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — Completed
• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
• ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD) — Completed
• Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME — Running, not enrolling
• A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. — Stopped early
• A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration — Completed
• The Evaluation of the Agreement Between the NVHO in the Automatic Fluid Quantification and Cirrus OCT — Completed